CreaTag™ Procainamide Glycan Labeling Kit, sodium cyanoborohydride Contained, 96x [For Glycan Labeling] (CAT#: CB-P292-K) Datasheet

Product Type
Kit
Description
The kit contains reagents for coupling the dye to the free reducing end of the glycan through a reductive amination reaction.
Features
Number of Samples: 96 separate analytical samples per set of labeling reagents
Amount of Sample: From 25 pmol up to 25 nmol glycans per sample.
Suitable Samples: Any purified glycans with free reducing termini can be labeled.
Structural Integrity: No detectable (< 2 mole per cent) loss of sialic acid, fucose, sulfate, or phosphate.
Labeling Selectivity:Essentially stoichiometric labeling.
Applications
For labelling of free glycans with procainamide (PROC) sodium cyanoborohydride reductant. Kit sufficient for 96 samples.
Sample
Glycoproteins and glycopeptides containing N-linked glycans
Components
Each kit contains two labeling reaction sets. Each labeling reaction set consists of one vial of each of the following:
procainamide dye 130 mg
sodium cyanoborohydride 72 mg
30% acetic acid in DMSO 2000 µL
Handling Advice
Ensure that any glass, plastic ware or solvents used are free of glycosidases and environmental carbohydrates. Use powder-free gloves for all sample handling procedures and avoid contamination with environmental carbohydrate. • Once individual vials of reagents are opened, their contents should be used immediately and excess then discarded according to local safety rules.
Storage
Store at room temperature in the dark. Protect from sources of heat, light, and moisture. The reagents are stable for at least two years as supplied.
Shelf Life
Stability: Stable at least 12 months when stored properly. Several days exposure to ambient tempertures will not reduce activity.
Research Use
For research use only. Not for human or drug use

All products and services are for Research Use Only. Do Not use in humans.

ONLINE INQUIRY

Creative Biolabs has established a team of customer support scientists ready to discuss ADCC/CDC optimization strategies, antibody production, bioinformatics analysis and other molecular biology/biotechnology issues.

  • *
  • *
  • *
USA

UK